外科領域におけるMezlocillinの基礎的ならびに臨床的検討 (Mezlocillin論文特集号)
スポンサーリンク
概要
- 論文の詳細を見る
Fundamental and clinical investigations on mezlocillin, a new penicillin antibiotic, was carried out.<BR>1. Antibacterial activity of mezlocillin was tested against various organisms isolated clinically in surgical field. Mezlocillin showed slightly better sensitivity against <I>E. coli</I> and <I>Enterobacter</I> than carbenicillin and it showed the same sensitivity against other organisms isolated.<BR>2. The average serum level was about 30μg/ml after intravenous injection of 1 g, about 14μg/ml at 1 hour.<BR>The average excretion into urine was about 48%(40-58%) in 6 hours.<BR>Mezlocillin attained the peak bile level of 1, 070μg/ml at 2 hours after drip infusion of 2g.<BR>3. Mezlocillin was administered to 9 cases, and clinical response was excellent in 1 case, good in 5 cases, moderate in 1 case and poor in 1 case, with effectiveness of 75%.<BR>No side effects due to the drug was seen in any case.
- 公益社団法人 日本化学療法学会の論文
公益社団法人 日本化学療法学会 | 論文
- DISPOSITION OF 7432-8 IN RATS (I)
- CLINICAL STUDIES ON T-1220 IN SURGICAL CASES
- CLINICAL STUDIES OF PIVALOYLOXYMETHYL D-α-AMINOBENZYL-PENICILLINATE HYDROCHLORIDE IN SURGICAL INFECTIONS
- STUDIES ON AC-1370
- Primary treatment with a combination of cyclophosphamide, vincristine, and dacarbazine for recurrent malignant pheochromocytoma: A case report.